Showing 37–48 of 74 results

  • Sale! Getryl 3mg Tablets

    Getryl 3mg Tablets – Glimepiride

    Original price was: ₨ 690.Current price is: ₨ 670.

    Getryl (Glimepiride) 3mg Tablets are a prescription medication used to control blood sugar levels in individuals with type 2 diabetes mellitus. Glimepiride is the active ingredient in Getryl and belongs to a class of drugs known as sulfonylureas.

    Getryl works by stimulating the release of insulin from the pancreas and increasing the sensitivity of tissues to insulin. This helps lower blood sugar levels and improve glycemic control in individuals with type 2 diabetes.

  • Sale! Getryl 4mg Tablets

    Getryl 4mg Tablets – Glimepiride

    Original price was: ₨ 1,070.Current price is: ₨ 1,050.

    Getryl (Glimepiride) 4mg Tablets are a prescription medication used to control blood sugar levels in individuals with type 2 diabetes mellitus. Glimepiride is the active ingredient in Getryl and belongs to a class of drugs known as sulfonylureas.

    Getryl works by stimulating the release of insulin from the pancreas and increasing the sensitivity of tissues to insulin. This helps lower blood sugar levels and improve glycemic control in individuals with type 2 diabetes.

  • Sale! Getzid MR 30mg Tablets

    Getzid MR 30mg Tablets – Gliclazide

    Original price was: ₨ 281.Current price is: ₨ 270.

    Getzid MR (Gliclazide) 30mg Tablets are a prescription medication used to control blood sugar levels in individuals with type 2 diabetes mellitus. Gliclazide is the active ingredient in Getzid MR and belongs to a class of drugs known as sulfonylureas.

    Getzid MR works by stimulating the release of insulin from the pancreas and increasing the sensitivity of tissues to insulin. This helps lower blood sugar levels and improve glycemic control in individuals with type 2 diabetes.

  • Sale! Placeholder

    Getzid MR 60mg Tablets – Gliclazide

    Original price was: ₨ 467.Current price is: ₨ 450.

    Getzid MR (Gliclazide) 60mg Tablets are a prescription medication used to control blood sugar levels in individuals with type 2 diabetes mellitus. Gliclazide is the active ingredient in Getzid MR and belongs to a class of drugs known as sulfonylureas.

    Getzid MR works by stimulating the release of insulin from the pancreas and increasing the sensitivity of tissues to insulin. This helps lower blood sugar levels and improve glycemic control in individuals with type 2 diabetes.

  • Sale! Glucobay 100mg Tablets

    Glucobay 100mg Tablets – Acarbose

    Original price was: ₨ 478.Current price is: ₨ 460.

    Glucobay 100mg tablets contain the active ingredient Acarbose, which is an alpha-glucosidase inhibitor medication used to treat type 2 diabetes. Acarbose works by slowing down the breakdown of carbohydrates in the small intestine, which can help to lower blood sugar levels after a meal.

  • Sale! Glucobay 50mg Tablets

    Glucobay 50mg Tablets – Acarbose

    Original price was: ₨ 286.Current price is: ₨ 270.

    Glucobay 50mg tablets contain the active ingredient Acarbose, which is an alpha-glucosidase inhibitor medication used to treat type 2 diabetes. Acarbose works by slowing down the breakdown of carbohydrates in the small intestine, which can help to lower blood sugar levels after a meal.

  • Inosita (Sitagliptin) 100mg Tablets

    Brand Name: Inosita

    Generic Name: Sitagliptin

    Dosage Strength: 100mg

    Manufacturer: PharmaEvo Pharmaceutical (Pvt) Ltd.

    Packing: 28 Tablets

    Description and Usage:

    Sitagliptin, commonly known by its brand name Inosita, is a medication primarily used to treat type 2 diabetes mellitus. It belongs to a class of drugs called dipeptidyl peptidase-4 (DPP-4) inhibitors. Sitagliptin works by increasing the levels of incretin hormones in the body, which help to regulate blood sugar levels by stimulating the release of insulin and decreasing the production of glucagon.

    Sitagliptin works by inhibiting the enzyme dipeptidyl peptidase-4 (DPP-4), which in turn increases the levels of incretin hormones such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). These hormones stimulate insulin release from pancreatic beta cells and decrease glucagon secretion from pancreatic alpha cells, thereby reducing blood glucose levels.

  • Inosita (Sitagliptin) 50mg Tablets

    Brand Name: Inosita

    Generic Name: Sitagliptin

    Dosage Strength: 50mg

    Manufacturer: PharmaEvo Pharmaceutical (Pvt) Ltd.

    Packing: 28 Tablets

    Description and Usage:

    Sitagliptin, commonly known by its brand name Inosita, is a medication primarily used to treat type 2 diabetes mellitus. It belongs to a class of drugs called dipeptidyl peptidase-4 (DPP-4) inhibitors. Sitagliptin works by increasing the levels of incretin hormones in the body, which help to regulate blood sugar levels by stimulating the release of insulin and decreasing the production of glucagon.

    Sitagliptin works by inhibiting the enzyme dipeptidyl peptidase-4 (DPP-4), which in turn increases the levels of incretin hormones such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). These hormones stimulate insulin release from pancreatic beta cells and decrease glucagon secretion from pancreatic alpha cells, thereby reducing blood glucose levels.

  • Placeholder

    Inosita Plus 50/1000mg Tablets – Sitagliptin+Metformin HCl

    Brand Name: Inosita Plus

    Generic Name: Sitagliptin + Metformin HCl

    Dosage Strength: 50mg Sitagliptin + 1000mg Metformin HCl

    Manufacturer: PharmaEvo Pharmaceutical (Pvt) Ltd.

    Packing: 28 Tablets

    Description and Usage:

    Inosita Plus (Sitagliptin+Metformin HCl) 50/1000mg Tablets are indicated for the management of type 2 diabetes mellitus in adults. This combination medication helps to control blood sugar levels by multiple mechanisms of action.

    • Sitagliptin: Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by inhibiting the enzyme DPP-4, which in turn increases the levels of incretin hormones such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). These hormones stimulate insulin release from pancreatic beta cells and decrease glucagon secretion from pancreatic alpha cells, thereby reducing blood glucose levels.
    • Metformin Hydrochloride: Metformin is a biguanide medication that works primarily by decreasing hepatic glucose production and increasing peripheral glucose uptake and utilization. It also improves insulin sensitivity in peripheral tissues such as muscle and adipose tissue.
  • Inosita Plus 50/500mg Tablets

    Inosita Plus 50/500mg Tablets – Sitagliptin+Metformin HCl

    Brand Name: Inosita Plus

    Generic Name: Sitagliptin + Metformin HCl

    Dosage Strength: 50mg Sitagliptin + 500mg Metformin HCl

    Manufacturer: PharmaEvo Pharmaceutical (Pvt) Ltd.

    Packing: 28 Tablets

    Description and Usage:

    Inosita Plus (Sitagliptin+Metformin HCl) 50/500mg Tablets are indicated for the management of type 2 diabetes mellitus in adults. This combination medication helps to control blood sugar levels by multiple mechanisms of action.

    • Sitagliptin: Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by inhibiting the enzyme DPP-4, which in turn increases the levels of incretin hormones such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). These hormones stimulate insulin release from pancreatic beta cells and decrease glucagon secretion from pancreatic alpha cells, thereby reducing blood glucose levels.
    • Metformin Hydrochloride: Metformin is a biguanide medication that works primarily by decreasing hepatic glucose production and increasing peripheral glucose uptake and utilization. It also improves insulin sensitivity in peripheral tissues such as muscle and adipose tissue.
  • Inosita Plus 50/850mg Tablets

    Inosita Plus 50/850mg Tablets – Sitagliptin+Metformin HCl

    Brand Name: Inosita Plus

    Generic Name: Sitagliptin + Metformin HCl

    Dosage Strength: 50mg Sitagliptin + 850mg Metformin HCl

    Manufacturer: PharmaEvo Pharmaceutical (Pvt) Ltd.

    Packing: 28 Tablets

    Description and Usage:

    Inosita Plus (Sitagliptin+Metformin HCl) 50/850mg Tablets are indicated for the management of type 2 diabetes mellitus in adults. This combination medication helps to control blood sugar levels by multiple mechanisms of action.

    • Sitagliptin: Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by inhibiting the enzyme DPP-4, which in turn increases the levels of incretin hormones such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). These hormones stimulate insulin release from pancreatic beta cells and decrease glucagon secretion from pancreatic alpha cells, thereby reducing blood glucose levels.
    • Metformin Hydrochloride: Metformin is a biguanide medication that works primarily by decreasing hepatic glucose production and increasing peripheral glucose uptake and utilization. It also improves insulin sensitivity in peripheral tissues such as muscle and adipose tissue.
  • Inosita Plus XR (Sitagliptin+Metformin HCl) 100/1000mg Tablets

    Brand Name: Inosita Plus XR

    Generic Name: Sitagliptin + Metformin HCl

    Dosage Strength: 100mg Sitagliptin + 1000mg Metformin HCl

    Manufacturer: PharmaEvo Pharmaceutical (Pvt) Ltd.

    Packing: 14 Tablets Extended Release

    Description and Usage:

    Inosita Plus XR tablets combine two active ingredients: Sitagliptin and Metformin Hydrochloride (HCl). This combination medication is used in the treatment of type 2 diabetes mellitus to help control blood sugar levels.

    Inosita Plus XR (Sitagliptin+Metformin HCl) tablets are indicated for the management of type 2 diabetes mellitus in adults. This medication helps to control blood sugar levels by multiple mechanisms of action, including increasing insulin secretion and reducing hepatic glucose production.

    • Sitagliptin: Inhibits the enzyme dipeptidyl peptidase-4 (DPP-4), leading to increased levels of incretin hormones such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). This results in enhanced insulin secretion and decreased glucagon release, ultimately reducing blood glucose levels.
    • Metformin Hydrochloride: Decreases hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity by increasing peripheral glucose uptake and utilization.